EUCTR2020-003300-14-DK进行中（未招募）1 期
Botulinum Toxin A as Treatment for Chronic Postsurgical Pain Following LungCancer Surgery: a Randomized Controlled Pilot Trial
Department of Cardiothoracic Surgery, Aalborg Universityhospital0 个研究点目标入组 30 人开始时间: 2020年8月14日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Patients of 18 years of age or above.
- •2. Patients who have undergone pulmonary surgery because of suspicion
- •or confirmed pulmonary malignancies.
- •3. Patients who are radically treated for pulmonary malignancy
- •4. Patients who suffers from chronic pain or unpleasant sensations at the site of scar at least six months after surgery with fully healed surgical wounds.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 20
排除标准
- •1. Patients who cannot understand oral and written information.
- •2. Patients who were not radically operated.
- •3. Patients with other concomitant or other active cancer diseases.
- •4. Patients with chronic pain in the chest wall prior to surgery.
- •5. Pregnant women or women planning to get pregnant in the study period.
- •6. Patients with autoimmune neuromuscular diseases, sclerosis, peripheral
- •neuromuscular disturbances and general muscle weakness or atrophy.
- •7. Patients with intolerance or allergy to BOTOX®.
- •8. Patients who are at present treated with Onabotulinum toxin A or similar neuromuscular blocking drug or have received such in the past year.
研究者
相似试验
进行中（未招募）
1 期
Botulinum toxin type A as treatment for chronic facial muscle pain.Chronic myalgia (>6months) in the facial region.EUCTR2021-002784-21-SEVästra Götalandsregionen72
进行中（未招募）
1 期
How affect the salivary gland treatment with Botulinum neurotoxin type A oral health in patients suffer for drooling?HypersalivationMedDRA version: 18.0Level: LLTClassification code 10020746Term: HypersalivationSystem Organ Class: 100000004856EUCTR2015-000682-30-EETartu University Hospital90
已完成
不适用
se of Botulinum Toxin for Treatment of Idiopathic Rhinitisidiopathic rhinitisC08.460.799RBR-4jbw4sFaculdade de Medicina da Universidade de São Paulo
招募中
4 期
Efficacy of botulinum toxin A for the management of melasma: A split-face, randomized control studyClinical diagnosis of melasma with symmetrical involvement of both malar areasMelasmaTCTR20240721002Division of Dermatology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand30
尚未招募
不适用
The combination treatment of Botulinum toxin and ablative fractional CO2 lasering to prevent scar formation after thyroidectomy and removal of neck massKCT0006396The Catholic University of Korea, St. Vincent's Hospital75